Munich - Delayed Quote EUR
Theriva Biologics Inc. R (SFY0.MU)
As of October 31 at 9:19 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-17,827.0000
-18,996.0000
-19,082.0000
-12,890.0000
-12,168.0000
Investing Cash Flow
-186.0000
-202.0000
-4,396.0000
-14.0000
-9.0000
Financing Cash Flow
317.0000
625.0000
-1,930.0000
74,002.0000
3,359.0000
End Cash Position
16,652.0000
23,279.0000
41,885.0000
67,325.0000
6,227.0000
Capital Expenditure
-186.0000
-202.0000
-116.0000
-14.0000
-9.0000
Issuance of Capital Stock
1,903.0000
2,219.0000
2,734.0000
65,960.0000
3,359.0000
Repayment of Debt
-67.0000
-75.0000
-1,376.0000
--
--
Repurchase of Capital Stock
--
--
-288.0000
--
--
Free Cash Flow
-18,013.0000
-19,198.0000
-19,198.0000
-12,904.0000
-12,177.0000
12/31/2020 - 1/12/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6C1.SG CytomX Therapeutics Inc
0.9245
+0.05%
BT1.F BioSenic S.A.
0.0114
-0.87%
6C1.F CytomX Therapeutics, Inc.
0.8400
+7.35%
6JH.SG IN8bio Inc
0.3060
+0.66%
6C1.BE CytomX Therapeutics Inc
0.9405
+1.35%
6JH.F IN8bio, Inc.
0.2960
-10.30%
6C1.DU CytomX Therapeutics Inc
0.9245
+0.11%
APTA.L Aptamer Group plc
0.2500
+8.70%
VAL.L ValiRx plc
1.6000
+4.92%
NRXPW NRx Pharmaceuticals, Inc.
0.0631
0.00%